| Literature DB >> 22918878 |
M David Stewart1, Jian Ming Deng, C Allison Stewart, Rachael D Mullen, Ying Wang, Suhujey Lopez, M Katalina Serna, Cheng-Chiu Huang, Jo Ann Janovick, Andrew J Pask, Robert J Schwartz, P Michael Conn, Richard R Behringer.
Abstract
GnRH, produced in the hypothalamus, acts on pituitary gonadotropes to stimulate release of the gonadotropins LH and FSH. Reduced responsiveness of gonadotropes to GnRH is a primary cause of hypogonadotropic hypogonadism (HH), a disease characterized by gonadal dysfunction and low blood levels of gonadotropins. Loss-of-function mutations in the gene encoding the receptor for GnRH (GNRHR) are a common cause of HH. Sequencing of the GNRHR gene in patients with HH revealed mainly point mutations producing single amino acid substitutions that cause misfolding and misrouting of this G protein-coupled receptor. To generate a mouse model that mimics the human disease, we introduced a single amino acid substitution (E90K) into the mouse Gnrhr gene, which is identical to a known human recessive mutation. In humans, E90K causes severe HH by preventing formation of the E90-K121 salt bridge, which is essential for correct folding. In cell cultures, E90K causes misfolding that leads to almost complete retention by the protein quality control system and subsequent degradation. Here we report that the primary phenotype of mice homozygous for E90K is female infertility due to ovulation failure. Mutant males are fertile despite reduced gonadotropin levels and smaller testes. These results suggest decreased GnRH receptor signaling in the mutant animal, compared with wild type. Our findings suggest that a threshold level of GnRH receptor activity is required for ovulation.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22918878 PMCID: PMC3487620 DOI: 10.1210/me.2012-1072
Source DB: PubMed Journal: Mol Endocrinol ISSN: 0888-8809